SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-12-039430
Filing Date
2012-07-13
Accepted
2012-07-13 16:53:47
Documents
3
Period of Report
2012-07-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v318424_8k.htm 8-K 29001
2 EXHIBIT 10.18 v318424_ex10-18.htm EX-10.18 37053
3 EXHIBIT 99.1 v318424_ex99-1.htm EX-99.1 10566
  Complete submission text file 0001144204-12-039430.txt   77922
Mailing Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277
Business Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Filer) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51462 | Film No.: 12962250
SIC: 2836 Biological Products, (No Diagnostic Substances)